Advanced Elegance, Outstanding Staff of 2021 Group Company, Wang Bingbing Gone from Behind the Scene to the Front
Release time:
2022-12-13
Wang Bingbing is "Old Peak " who has been working in Jianfeng Group since graduation. Graduated from Shenyang Pharmaceutical University in 2009 and entered the central laboratory of Jianfeng Pharmaceutical Company. 2013 went to Jianfeng Health to engage in quality and research and development. The following year he transferred to market management. 2020 was also in charge of sales due to personnel adjustment, responsible for docking the company's direct management of customers.
Market management is mainly responsible for product promotion, sales channel layout, etc., comparing sales, similar to the role of behind-the-scenes operation planning. When he went to the front of the stage and started his own practical exercises, Wang Bingbing found out that this was completely different from his previous understanding when watching other people's operations. There are thousands of customers, some kind and easy-to-talk, some honest and frank, some haggle over every ounce, and some are more emotional. How to communicate with customers and deal with various situations is a big test for Wang Bingbing. "I have learned more in actual work than in school " .
In the most extreme case, Wang Bingbing was scolded and cried several times by a strong customer. That customer is the first time to contact the health food industry. He pursues perfection and is very concerned about whether things develop according to his own ideas. The product packaging is designed by himself, and the packaging materials are also his own choice. The products commissioned by
are 2 liquid soft bags with different formulas (day and night combination). One of the raw materials will be heated to produce gas during processing, and will bulge a little when bagging. The other raw material has no gas production phenomenon and is relatively flat. After packing, one of the two boxes will appear full and the other will appear loose. Wang Bingbing and his colleagues didn't care. The customer looked at it carefully and felt it with his hand. He was very unhappy and asked for repackaging. He opened the box again and found that there were some dots and some strips of glue in the box. He felt very unsightly and unprofessional. He was furious and scolded Wang Bingbing and his colleagues.
Grievance belongs to injustice. In line with the service concept of customer first, Wang Bingbing quickly arranged for urgent rework. The box was redone and the bag was repackaged, so the customer was relieved. After the order was completed normally, the other party also asked his colleagues to apologize, which means "no deal " .
Health care products have a high degree of personalization, with many types and ways of materials and packaging, and customized packaging designs are even more varied. And each customer has his own appeal and expression, the packaging of e-commerce channels should be fancy, those for female consumers should be colorful, and those for middle-aged and elderly groups should be stable and atmospheric, mainly red and gold. Every time the outer packaging is designed, it is common for customers to pick several or more than a dozen schemes in a row.
has a customer who processes spore oil. His two brands are divided into multiple distributors, each with different packaging. The products are divided into 30 grain package, 60 grain package, 120 grain package, etc. The number of bottles in a box is different, and each bottle is divided into different grain numbers. There are dozens of specifications after cross calculation, while the bottles, sealing labels, anti-fake codes, instructions, folds, sulfuric acid paper, etc. used in different specifications are also different. In case of this kind of situation, Wang Bingbing will make his own small account, print out the list, check it repeatedly at any time and check with customers regularly.
When designing packaging, customers sometimes have clear demands and have to make it look like so-and-so. Sometimes I don't know what I want, and I only have a vague feeling in my heart. Look at similar products on the market. This one has good packaging and which one has good packaging and wants to imitate and learn. After much contact, Wang Bingbing gained experience and kept the packaging design he had done before for customers' reference and selection. When Wang Bingbing brought her products to the exhibition for publicity, she met a customer who especially liked to imitate, which left a deep impression on her. The other party asked many design companies before looking for it, but they still felt that it was not enough. They asked Wang Bingbing to see all the design drafts in her hand. Some sample boxes were commissioned by other companies for healthy processing. The customer's information was not convenient to send out, and Wang Bingbing did not give it. As a result, he went to the box in the background of the exhibition and forcibly brought the sample boxes, which made people laugh and cry.
Wang Bingbing was impatient and introverted before. Through communicating with customers, she also became much more easygoing and cheerful. On the whole, Wang Bingbing thinks that he is relatively lucky, and the change of work is smooth and smooth. With the experience accumulated in following up products in quality and R & D positions, he has a detailed understanding of the details of the products, and has a reasonable basis for communicating with customers, which makes it easier for them to be convinced. However, she tries hard to treat her customers in the same way as friends, family members or best friends, so that both parties can make money and have good continuity after talks.
In the past two years, the impact of the epidemic and the economic situation, all kinds of exhibitions postponed, offline activities blocked, health care products sales encountered certain difficulties, Wang Bingbing himself also quite coincidentally experienced "where to isolate " stage, ran several places in a row, all encountered the epidemic point. Once she was in a hurry to visit customers in Hangzhou. When the prevention and control situation at the destination was stable, she was busy rushing over and broke out again. She was quarantined when she returned to gold and almost missed the New Year. However, Wang Bingbing believes that the difficulties are temporary. If we conscientiously sum up experience, overcome shortcomings, and work harder to grow and learn, we will certainly be able to do a better job in the future.
(Reporter Chen Shengmu)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31